Precision Primary Care

Reducing ​Antibiotic ​Misuse with ​Innovative ​Diagnostics


Dedicated to reducing antibiotic misuse, our ​mission is to provide primary care providers with ​advanced, cost-effective diagnostic tools. Our ​state-of-the-art screening device, offered at ​highly accessible pricing, has the potential to ​penetrate markets that cannot accommodate ​more expensive equipment or where rapid ​diagnostics are crucial. In doing so, we aim to ​enhance patient outcomes, reduce unnecessary ​expenditures, and address the challenge of ​antibiotic resistance.


Developed by Brazilian Ministry of Science and Technology ​(MCTI). It is ready for submission to the FDA, EMA, and ANVISA.

Modern Shapes and Frames Line Burst

PUBLICATIONS AND AWARDS

How it works

Modern Shapes and Frames Line Burst

Collection

1

Performed using a swab

Reading

2

In seconds, identify ​whether the infection is ​microbial or viral

Tr​eatment

3

Recommend the most ​appropriate therapy

Expert

PhD. Talita Mazon

With dual PhDs and eighteen years in the ​field of advanced materials and ​microsystems, she is among the Brazilian ​researchers with the highest number of ​approved studies by the Ministry of Science a​nd Technology (MCTI).

Track record

2˚ place Innovation Award

Fleury Laboratories

Public traded as FLRY3

Brazil’s largest and most respected ​healthcare organization.

https://ri.fleury.com.br/en/who-we-​are/

Zimbra

https://webmail.cti.gov.br/zimbra/h/printmessage?id...

Zimbra

VI Prêmio de Inovação do Grupo Fleury - Entrega de troféu

tmazon@cti.gov.br

De : ​Assunto :

Para :

Fleury Lab <fleurylab@grupofleury.com.br> ​VI Prêmio de Inovação do Grupo Fleury - Entrega

de troféu

talita mazon <talita.mazon@cti.gov.br>

qui, 10 de dez de 2020 10:03 ​3 anexos

Olá Talita, ​Mais uma vez, parabéns por sua colocação final no VI Prêmio de Inovação ​do Grupo Fleury! ​O vídeo de divulgação dos vencedores está disponível nas redes sociais ​do Fleury LAB, e ​você também pode rever o evento do dia 04 de dezembro clicando aqui. ​Gostaríamos de confirmar com você o endereço para envio do troféu de ​sua iniciativa. Para ​isso, responda a este e-mail informando o local em que o mesmo deve ser ​entregue. ​Agradecemos a sua participação nesse processo e sua dedicação em ​inciativas que podem ​auxiliar muito nossa sociedade neste momento! ​Abraços,

Avaliação Final - Testes Portáteis.pdf

312 KB

1 of 1

17/06/2024, 11:37

NDA

Dasa Diagnostics

Public traded as DASA3

World's largest medical test processing ​facility.

https://www.dasa3.com.br/en/

Paper published in

Nature.com

USD+4M Raised

Public and private

Open in googledocs